NBIX

Neurocrine Biosciences, Inc.

Ten-year history of valuation, safety, growth and profitability, with percentile bands against NBIX’s own range.

Snapshot

P/E

29.5×

P56

Yield

n/a

FCF payout

0.0%

P50

Net debt / EBITDA

0.37

P27

DGR 5y

n/a

ROIC

3.0%

P87

Value

Is the share cheap or dear by its own history?

NBIX is mid-band on valuation. P/E at P56 (29.5x); yield at n/a.

Partial data in this window.

Safety

Can the business comfortably cover the dividend?

FCF payout sits at P50 (0%) of its history. Leverage (Net Debt/EBITDA) at P27 (0.37); interest cover at P65 (52.76).

Growth

Is the dividend and the cash behind it still growing?

5-year dividend growth at n/a of its 10y range. FCF growth P0 (65%); ROIC P87 (3%).

Partial data in this window.

Profitability

Is the engine getting better or worse at making money?

Gross margin at P10 (98%) of its history. Operating margin P100 (23%); net margin P99 (21%).

Forecast your income with the NBIX dividend calculator

Free account

Sign up free to look up 10 stocks a day.

Anonymous lookups are capped at three a day. A free account bumps that to ten, and your counter resets at midnight UK time.

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.